In the US, Eltrombopag (eltrombopag systemic) is a member of the drug class platelet-stimulating agents and is used to treat Idiopathic Thrombocytopenic Purpura and Thrombocytopenia Idiopathic.
US matches:
- Eltrombopag
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
B02BX05
CAS registry number (Chemical Abstracts Service)
0496775-61-2
Chemical Formula
C25-H22-N4-O4
Molecular Weight
442
Therapeutic Categories
Platelet stimulating factor
Thrombopoietin receptor agonist
Chemical Names
(Z)-3'-{N'-[1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazolyliden]hydrazin}-2'-hydroxybiphenyl-3-carbonsäure (IUPAC)
[1,1'-Biphenyl]-3-carboxylic acid, 3'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-
3'-{(2Z)-2-[1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1,5-dihydro-4H-pyrazol-4-ylidene]diazanyl}-2'-hydroxybiphenyl-3-carboxylic acid (WHO)
Foreign Names
- Eltrombopagum (Latin)
- Eltrombopag (German)
- Eltrombopag (French)
- Eltrombopag (Spanish)
Generic Names
- SB 497115 (IS)
- UNII-S56D65XJ9G (IS)
- Eltrombopag Olamine (OS: USAN)
- SB-497115-GR (IS)
- UNII-4U07F515LG (IS)
Brand Names
- Promacta
GlaxoSmithKline, United States - Revolade
GlaxoSmithKline, Germany
International Drug Name Search
Glossary
IUPAC | International Union of Pure and Applied Chemistry |
IS | Inofficial Synonym |
OS | Official Synonym |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
USAN | United States Adopted Name |
WHO | World Health Organization |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment